<GlossaryTerm id="CDR0000528028"><TermName>tandutinib</TermName><TermPronunciation>(tan-DOO-tih-nib)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of cancer. It may stop cancer cell growth by blocking certain enzymes. It may also prevent the growth of new blood vessels that  tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called CT53518 and MLN518.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718662" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tandutinib&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718661" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tandutinib&quot;" language="es" id="_4"/><SpanishTermName>tandutinib</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. Es posible que evite la multiplicación de células cancerosas al bloquear ciertas enzimas. Además, quizás impida  la formación de  vasos sanguíneos nuevos que los tumores necesitan para crecer. Es un tipo de antiangiogénico y de inhibidor de tirosina–cinasas. También se llama CT53518 y MLN518.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-05-11</DateFirstPublished><DateLastModified>2009-04-21</DateLastModified></GlossaryTerm>
